ProCE Banner Activity

Individualizing Treatment for Patients With RA, axSpA, and PsA: Considerations and Strategies

Clinical Thought

This expert commentary offers a review of the key considerations for managing patients with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis using the latest guideline recommendations.

Released: September 14, 2022

Expiration: September 13, 2023

Begin Activity

Share

Faculty

Jennifer Simpson

Jennifer Simpson, DNP

Nurse Practitioner
Arizona Arthritis & Rheumatology Associates
Phoenix, Arizona

Acknowledgement

This activity is supported by educational grants from Amgen; and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Target Audience

NPs and PAs in rheumatology and primary care

Disclosure

Jennifer Simpson, DNP: consultant/advisor/speaker: AbbVie, Amgen, AstraZeneca, Horizon, Janssen.

Format

ClinicalThought Commentary

Additional Information

Program Medium

This program has been made available online.